NCT02496741View on ClinicalTrials.gov

Metformin And Chloroquine in IDH1/2-mutated Solid Tumors

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

November 18, 2019

Study Completion Date

November 18, 2019

Conditions
GliomaCholangiocarcinomaChondrosarcoma
Interventions
DRUG

Metformin and chloroquine combination

Metformin and chloroquine are two oral medications. Metformin is to be taken twice daily, chloroquine once daily.

Trial Locations (3)

1081 HZ

VU University Medical Center, Amsterdam

1105AZ

Academic Medical Center, Amsterdam

2333 ZA

Leiden University Medical Center, Leiden

All Listed Sponsors
lead

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER

NCT02496741 - Metformin And Chloroquine in IDH1/2-mutated Solid Tumors | Biotech Hunter | Biotech Hunter